BR9911769B8 - composição para impedir ou reduzir a incidência de aderências pós-operatória em ou associadas com uma cavidade do corpo, kit de prevenção de adesão pós-operatória biocompatível, bioabsorvível e não tóxico e produtos ompreendendo a dita composição - Google Patents

composição para impedir ou reduzir a incidência de aderências pós-operatória em ou associadas com uma cavidade do corpo, kit de prevenção de adesão pós-operatória biocompatível, bioabsorvível e não tóxico e produtos ompreendendo a dita composição

Info

Publication number
BR9911769B8
BR9911769B8 BRPI9911769A BR9911769A BR9911769B8 BR 9911769 B8 BR9911769 B8 BR 9911769B8 BR PI9911769 A BRPI9911769 A BR PI9911769A BR 9911769 A BR9911769 A BR 9911769A BR 9911769 B8 BR9911769 B8 BR 9911769B8
Authority
BR
Brazil
Prior art keywords
composition
post
operative
body cavity
incidence
Prior art date
Application number
BRPI9911769A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9911769A (pt
BR9911769B1 (pt
Inventor
Brown Colin
Original Assignee
Innovata Ltd
Innovata Plc
Ml Laboratories Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810127.2A external-priority patent/GB9810127D0/en
Application filed by Innovata Ltd, Innovata Plc, Ml Laboratories Plc filed Critical Innovata Ltd
Publication of BR9911769A publication Critical patent/BR9911769A/pt
Publication of BR9911769B1 publication Critical patent/BR9911769B1/pt
Publication of BR9911769B8 publication Critical patent/BR9911769B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI9911769A 1998-05-13 1999-05-13 composição para impedir ou reduzir a incidência de aderências pós-operatória em ou associadas com uma cavidade do corpo, kit de prevenção de adesão pós-operatória biocompatível, bioabsorvível e não tóxico e produtos ompreendendo a dita composição BR9911769B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9810127.2 1998-05-13
GBGB9810127.2A GB9810127D0 (en) 1998-05-13 1998-05-13 Prevention of surgical adhesions
US27271399A 1999-03-19 1999-03-19
US09/272,713 1999-03-19
PCT/GB1999/001306 WO1999058168A1 (en) 1998-05-13 1999-05-13 Dextrin-containing composition for preventing surgical adhesions

Publications (3)

Publication Number Publication Date
BR9911769A BR9911769A (pt) 2001-02-06
BR9911769B1 BR9911769B1 (pt) 2014-10-07
BR9911769B8 true BR9911769B8 (pt) 2021-06-22

Family

ID=26313653

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9911769A BR9911769B8 (pt) 1998-05-13 1999-05-13 composição para impedir ou reduzir a incidência de aderências pós-operatória em ou associadas com uma cavidade do corpo, kit de prevenção de adesão pós-operatória biocompatível, bioabsorvível e não tóxico e produtos ompreendendo a dita composição

Country Status (16)

Country Link
EP (1) EP1085920B1 (enExample)
JP (2) JP3679710B2 (enExample)
CN (1) CN1181894C (enExample)
AT (1) ATE211002T1 (enExample)
AU (1) AU740832B2 (enExample)
BR (1) BR9911769B8 (enExample)
CA (1) CA2331672C (enExample)
DE (1) DE69900648T2 (enExample)
DK (1) DK1085920T3 (enExample)
ES (1) ES2165735T3 (enExample)
IL (2) IL139283A0 (enExample)
NO (1) NO312709B1 (enExample)
NZ (2) NZ507832A (enExample)
PL (1) PL194109B1 (enExample)
PT (1) PT1085920E (enExample)
WO (1) WO1999058168A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363713A (en) * 2000-06-21 2002-01-09 Ml Lab Plc Dextrin compositions
CA2392666C (en) * 2000-01-21 2011-12-13 Ml Laboratories Plc Dextrin containing compositions for prevention of adhesions
GB0115505D0 (en) * 2001-06-25 2001-08-15 Britannia Pharmaceuticals Ltd Prevention of surgical adhesions
US8252333B2 (en) * 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
US8455001B2 (en) 2007-02-06 2013-06-04 Teijin Limited Cellulose derivative and method for production thereof
DE102008005172A1 (de) * 2008-01-19 2009-07-23 Mike Ehrlich Pharmazeutische Zusammensetzung zur Verhinderung von post-operativen Adhäsionen
EP2676682A1 (en) * 2011-02-08 2013-12-25 Jorge Cueto García Thixotropic biological adhesive for use in internal body cavities
US20220265896A1 (en) * 2019-08-01 2022-08-25 Km Biologics Co., Ltd. Tissue fibrosis inhibitor in which biocompatible polymer is used

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207676B1 (en) * 1985-06-22 1994-06-01 M L Laboratories Plc Polymers for use in continuous peritoneal dialysis
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5093319A (en) * 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
EP0426368B1 (en) * 1989-10-31 1995-01-04 Howmedica Inc. Compositions containing derivatives of chitin for preventing adhesion
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5614515A (en) * 1994-11-17 1997-03-25 University Of Southern California Lazaroid-based compositions and method for preventing adhesion formation using the same
US5807833A (en) * 1995-06-07 1998-09-15 University Of Southern California Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
CA2223590A1 (en) * 1995-06-07 1996-12-19 The University Of Southern California Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
JP3925955B2 (ja) * 1996-04-26 2007-06-06 株式会社クラレ 癒着防止材
IN192791B (enExample) * 1996-06-28 2004-05-22 Johnson & Johnson Medical

Also Published As

Publication number Publication date
JP4276601B2 (ja) 2009-06-10
CA2331672C (en) 2007-02-06
NO20005492L (no) 2001-01-12
BR9911769A (pt) 2001-02-06
ES2165735T3 (es) 2002-03-16
DE69900648D1 (de) 2002-01-31
CN1181894C (zh) 2004-12-29
JP2005047929A (ja) 2005-02-24
EP1085920B1 (en) 2001-12-19
NO20005492D0 (no) 2000-11-01
AU740832B2 (en) 2001-11-15
EP1085920A1 (en) 2001-03-28
CA2331672A1 (en) 1999-11-18
NZ523994A (en) 2004-11-26
NZ507832A (en) 2003-03-28
PL344536A1 (en) 2001-11-05
JP2003528026A (ja) 2003-09-24
HK1034680A1 (en) 2001-11-02
BR9911769B1 (pt) 2014-10-07
PL194109B1 (pl) 2007-04-30
CN1300226A (zh) 2001-06-20
NO312709B1 (no) 2002-06-24
ATE211002T1 (de) 2002-01-15
JP3679710B2 (ja) 2005-08-03
IL139283A (en) 2007-02-11
AU3833699A (en) 1999-11-29
DE69900648T2 (de) 2002-07-04
PT1085920E (pt) 2002-06-28
IL139283A0 (en) 2001-11-25
DK1085920T3 (da) 2002-04-15
WO1999058168A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
MXPA03010448A (es) Metodo y composicion para reducir la union de bacterias a biomateriales.
NO20021013L (no) Vandig geldannet blanding som omfatter en blokk-kopolymer inkluderende minst en vannopplöselig blokk og en hydrofob blokk
AU660282B2 (en) Water insoluble derivatives of hyaluronic acid
ATE113636T1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
MX9700443A (es) Agente que estimula el tejido duro.
AU5062499A (en) Dental pin
WO1997007833A3 (en) Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives
FR11C0037I1 (enExample)
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
AU612085B1 (en) Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
PT820239E (pt) Massa de cobertura para uso em microondas que compreende amilase
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
ZA99476B (en) Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion.
ATE226439T1 (de) Anti-adhäsionsmittel
AU2002367979A1 (en) Devices, systems and methods for reducing levels of pro-inflammartory or anti-inflammatrory stimulators or mediators in blood products
BR9911769B8 (pt) composição para impedir ou reduzir a incidência de aderências pós-operatória em ou associadas com uma cavidade do corpo, kit de prevenção de adesão pós-operatória biocompatível, bioabsorvível e não tóxico e produtos ompreendendo a dita composição
AU7313896A (en) Pharmaceutical composition containing an activin or inhibin stimulator
BR9609499A (pt) Tablete de polímero de ioneno método para fazer uma composição de polímero de ioneno de tablete e método para controlar o crescimento de microorganismos em um sistema aquoso
AU2525601A (en) Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
AU3114095A (en) Aqueous coating composition giving coatings having improved early hardness and tack-resistance
BR9906350A (pt) Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps
CA2309653A1 (en) Use of protein h as cytostatic agent
AU2003227847A1 (en) Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: INNOVATA PLC (GB)

Free format text: ALTERADO DE: ML LABORATORIES PLC

B25G Requested change of headquarter approved

Owner name: INNOVATA PLC (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060170273/RJ DE 10/11/2006.

B25D Requested change of name of applicant approved

Owner name: INNOVATA LIMITED (GB)

Free format text: ALTERADO DE: INNOVATA PLC

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/10/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 22A ANUIDADE.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/1999, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 14/05/2019